[Connection between uterine myomas and biochemical screening results in the first and second trimester of pregnancy]
- PMID: 20120938
[Connection between uterine myomas and biochemical screening results in the first and second trimester of pregnancy]
Abstract
Objectives: Uterine myomas may change the concentrations of the screening serum markers and therefore alter the risk calculation of the fetal chromosomal abnormalities. An increased risk leads to invasive diagnostics procedures which in these cases can often be technically difficult due to the presence of myomas.
Aim: The aim of this study was to assess the influence of uterine myomas on the first and second trimester serum markers concentrations and, possibly on the test results.
Material and methods: The study group consisted of 127 women between 11 and 20 weeks of normal singleton pregnancy. In each case uterine myomas were diagnosed--over 20 mm in the diameter and located in the uterine wall. 77 patients underwent the first trimester screening (PAPP-A & free beta-hCG) and 50 patients had the second trimester screening (triple test). The control group consisted of 1020 women between 11 and 20 weeks of normal singleton pregnancy without uterine myomas. Delfia Xpress analyser was used for the serum markers estimations. All pregnant women delivered normal healthy babies.
Results: In the first trimester group the PAPP-A serum concentrations were not different from the controls while the mean median concentration of free beta-hCG were significant higher--1.43 MoM. In the second trimester group the following mean median values were observed: no significance for the AFP--1.18 MoM and estriol--1.29 MoM and significantly higher mean median value for the free beta-hCG--2.01 MoM.
Conclusions: 1. The presence of the uterine myomas is connected with the increased maternal serum concentration of the beta-hCG, particularly in the second trimester. 2. The uterine myomas may lead to the increased rate of the false positive results of the prenatal screening test, especially the triple test.
Similar articles
-
Association between uterine leiomyomas and the biochemical screening test results in the first and second trimester of pregnancy: a pilot study.J Matern Fetal Neonatal Med. 2011 Jul;24(7):904-6. doi: 10.3109/14767058.2010.536864. Epub 2011 Apr 4. J Matern Fetal Neonatal Med. 2011. PMID: 21463216
-
Prediction of pregnancy complications by first-trimester maternal serum PAPP-A and free beta-hCG and with second-trimester uterine artery Doppler.Prenat Diagn. 2005 Oct;25(10):949-53. doi: 10.1002/pd.1251. Prenat Diagn. 2005. PMID: 16086443
-
Maternal serum free-beta-chorionic gonadotrophin, pregnancy-associated plasma protein-A and fetal nuchal translucency thickness at 10-13(+6) weeks in relation to co-variables in pregnant Saudi women.Prenat Diagn. 2007 Apr;27(4):303-11. doi: 10.1002/pd.1661. Prenat Diagn. 2007. PMID: 17269128
-
First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of impending fetal death.Ultrasound Obstet Gynecol. 2006 Oct;28(5):637-43. doi: 10.1002/uog.3809. Ultrasound Obstet Gynecol. 2006. PMID: 16952214 Review.
-
First trimester prenatal screening biomarkers and gestational diabetes mellitus: A systematic review and meta-analysis.PLoS One. 2018 Jul 26;13(7):e0201319. doi: 10.1371/journal.pone.0201319. eCollection 2018. PLoS One. 2018. PMID: 30048548 Free PMC article.
Cited by
-
Biomarkers in uterine leiomyoma.Fertil Steril. 2013 Mar 15;99(4):1146-52. doi: 10.1016/j.fertnstert.2012.10.048. Epub 2012 Nov 29. Fertil Steril. 2013. PMID: 23200685 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous